These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 31958057)
1. Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior. Goswami D; Chen D; Yang Y; Gudla PR; Columbus J; Worthy K; Rigby M; Wheeler M; Mukhopadhyay S; Powell K; Burgan W; Wall V; Esposito D; Simanshu DK; Lightstone FC; Nissley DV; McCormick F; Turbyville T Elife; 2020 Jan; 9():. PubMed ID: 31958057 [TBL] [Abstract][Full Text] [Related]
2. Organization of Farnesylated, Carboxymethylated KRAS4B on Membranes. Barklis E; Stephen AG; Staubus AO; Barklis RL; Alfadhli A J Mol Biol; 2019 Sep; 431(19):3706-3717. PubMed ID: 31330153 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic KRas mobility in the membrane and signaling response. Nussinov R; Tsai CJ; Jang H Semin Cancer Biol; 2019 Feb; 54():109-113. PubMed ID: 29499269 [TBL] [Abstract][Full Text] [Related]
5. PIP2 Influences the Conformational Dynamics of Membrane-Bound KRAS4b. McLean MA; Stephen AG; Sligar SG Biochemistry; 2019 Aug; 58(33):3537-3545. PubMed ID: 31339036 [TBL] [Abstract][Full Text] [Related]
6. Conserved allosteric perturbation of the GTPase domains by region 1 of Ras hypervariable regions. Gu X; Zhang Y; Long D Biophys J; 2024 Apr; 123(7):839-846. PubMed ID: 38419331 [TBL] [Abstract][Full Text] [Related]
7. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ. Ozdemir ES; Jang H; Gursoy A; Keskin O; Nussinov R J Phys Chem B; 2018 Aug; 122(30):7503-7513. PubMed ID: 29961325 [TBL] [Abstract][Full Text] [Related]
8. RAS G-domains allosterically contribute to the recognition of lipid headgroups and acyl chains. Arora N; Mu H; Liang H; Zhao W; Zhou Y J Cell Biol; 2024 May; 223(5):. PubMed ID: 38334958 [TBL] [Abstract][Full Text] [Related]
12. Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety. Grant BMM; Enomoto M; Back SI; Lee KY; Gebregiworgis T; Ishiyama N; Ikura M; Marshall CB Sci Signal; 2020 Mar; 13(625):. PubMed ID: 32234958 [TBL] [Abstract][Full Text] [Related]
13. N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation. Wu M; Huang J; Zhang J; Benes C; Jiao B; Ren R Mol Cancer Ther; 2017 Jan; 16(1):57-67. PubMed ID: 27760835 [TBL] [Abstract][Full Text] [Related]
14. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer. Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties. Whitley MJ; Tran TH; Rigby M; Yi M; Dharmaiah S; Waybright TJ; Ramakrishnan N; Perkins S; Taylor T; Messing S; Esposito D; Nissley DV; McCormick F; Stephen AG; Turbyville T; Cornilescu G; Simanshu DK Sci Adv; 2024 Feb; 10(7):eadj4137. PubMed ID: 38354232 [No Abstract] [Full Text] [Related]
16. High-throughput, single-particle tracking reveals nested membrane domains that dictate KRas Lee Y; Phelps C; Huang T; Mostofian B; Wu L; Zhang Y; Tao K; Chang YH; Stork PJ; Gray JW; Zuckerman DM; Nan X Elife; 2019 Nov; 8():. PubMed ID: 31674905 [TBL] [Abstract][Full Text] [Related]
17. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function. Cao S; Chung S; Kim S; Li Z; Manor D; Buck M J Biol Chem; 2019 Apr; 294(17):7068-7084. PubMed ID: 30792310 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region. Jang H; Abraham SJ; Chavan TS; Hitchinson B; Khavrutskii L; Tarasova NI; Nussinov R; Gaponenko V J Biol Chem; 2015 Apr; 290(15):9465-77. PubMed ID: 25713064 [TBL] [Abstract][Full Text] [Related]
19. Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles. Liao TJ; Jang H; Fushman D; Nussinov R Biophys J; 2018 Aug; 115(4):629-641. PubMed ID: 30097175 [TBL] [Abstract][Full Text] [Related]
20. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant? Nussinov R; Tsai CJ; Jang H Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]